Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancer
about
Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patientsObstetric and offspring risks of women's morbid conditions linked to prior anticancer treatmentsEndocrinopathies in survivors of childhood neoplasiaHuman OCT2 variant c.808G>T confers protection effect against cisplatin-induced ototoxicity.Effect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and ChildrenBridging translation for acute kidney injury with better preclinical modeling of human diseaseDesign and Methods of the Pan-Canadian Applying Biomarkers to Minimize Long-Term Effects of Childhood/Adolescent Cancer Treatment (ABLE) Nephrotoxicity Study: A Prospective Observational Cohort Study.Premature Ovarian Insufficiency in Childhood Cancer Survivors: A Report from the St. Jude Lifetime Cohort.Cisplatin nephrotoxicity: a review of the literature.Connectivity map identifies HDAC inhibition as a treatment option of high-risk hepatoblastomaOutcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532.Renal toxicity and chemotherapy in children with cancer.Renal Function Outcomes of High-risk Neuroblastoma Patients Undergoing Radiation Therapy.Severe acute kidney injury as presentation of Burkitt's lymphoma.Glomerular hyperfiltration and β-2 microglobulin as biomarkers of incipient renal dysfunction in cancer survivorsSevere fatigue in childhood cancer survivorsLate Effects and Survivorship Issues in Patients with Neuroblastoma
P2860
Q24186938-BAB33E49-455E-4DBC-8095-25CA443908DCQ26744055-8EF4D6BA-9D77-4620-A4A2-09E861C63DECQ27009171-DA95B5C3-AB7E-43B0-BF2B-A479B39A42C6Q27335267-F9756D9D-1A3F-4305-8A88-7C54A406E3D4Q36322918-3FC110D3-853B-46D8-9EE2-B92243693B52Q36957116-A2CB99BD-B7D3-4967-AC82-F17C3DA15261Q37652392-AFE855EC-EB01-4993-A8CD-95466BBB75BDQ38860945-A71F4B7E-5BB8-4BBE-88DA-45075707980BQ39223600-CBBCE06E-DF67-42B8-8FF8-019A4F6228DAQ41728555-849E11F9-57D2-4A47-9076-9F23CC80F26EQ47797328-3C0C8307-0B6A-4CF5-9C11-CA2F9A73AD3AQ48321401-5A24B569-96F3-4228-BEA5-A7FE57681537Q51798924-9CB9F5D6-298A-473A-AFC2-CC63D03E4803Q53113973-7060C03C-852F-4B67-858E-8145167AA97AQ57134277-A5001093-23C0-4C14-8449-7E96E504A628Q57253224-F08F8105-BE53-47AE-BC7A-BA4695D340D5Q58798636-E8D02609-DB21-442E-A114-AEDBB248C05B
P2860
Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancer
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Early and late renal adverse e ...... treatment for childhood cancer
@ast
Early and late renal adverse e ...... treatment for childhood cancer
@en
Early and late renal adverse e ...... treatment for childhood cancer
@nl
type
label
Early and late renal adverse e ...... treatment for childhood cancer
@ast
Early and late renal adverse e ...... treatment for childhood cancer
@en
Early and late renal adverse e ...... treatment for childhood cancer
@nl
prefLabel
Early and late renal adverse e ...... treatment for childhood cancer
@ast
Early and late renal adverse e ...... treatment for childhood cancer
@en
Early and late renal adverse e ...... treatment for childhood cancer
@nl
P2093
P2860
P3181
P1476
Early and late renal adverse e ...... treatment for childhood cancer
@en
P2093
Antoinette YN Schouten-Van Meeteren
Arend Bökenkamp
Eline van Dulmen-den Broeder
Hester Blufpand
Leontien CM Kremer
Margreet A Veening
Monique WM Jaspers
Renée L Mulder
Sebastiaan L Knijnenburg
P2860
P3181
P356
10.1002/14651858.CD008944.PUB2
P577
2013-10-08T00:00:00Z